The Wall Street Journal
Yousin Suh, a professor of reproductive sciences at Columbia, says her own experience with menopausal symptoms such as brain fog and sleep issues helped motivate her to work with Williams on the study. “I was stimulated by my own misery,” she says.
At Columbia, researchers Williams and Suh recently launched a pilot clinical trial testing low-dose rapamycin - a kidney transplant drug also being studied more broadly as an antiaging treatment - on 50 premenopausal women to see whether it could slow down ovarian aging.
